| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/01/1997 | US5643780 Compositions and methods for modulating RNA activity through modification of the 5' cap structure of RNA |
| 07/01/1997 | US5643778 RNA editing enzyme and methods of use thereof |
| 07/01/1997 | US5643772 Cryptosporidium hybrid vector and transformed host cells |
| 07/01/1997 | US5643759 Hybridoma cell lines |
| 07/01/1997 | US5643757 High yield production of human apolipoprotein A1 in E. coli. |
| 07/01/1997 | US5643755 Wound healing, antiischemic, blocking blood vessel growth |
| 07/01/1997 | US5643752 Culture of cells to produce polypeptides |
| 07/01/1997 | US5643749 Soluble interferon α-receptor, its preparation and use |
| 07/01/1997 | US5643748 HU-B1.219, a novel human hematopoietin receptor |
| 07/01/1997 | US5643741 Mixing cells with antibodies and binding |
| 07/01/1997 | US5643740 Diagnostic and therapeutic uses in cancer, autoimmune disease and transplant rejection |
| 07/01/1997 | US5643732 Immunological assay methods |
| 07/01/1997 | US5643729 Methods for diagnosing cancer, precancerous state, or susceptibility to other forms of diseases by detecting an acceleration of exon skipping in IRF-1 mRNA |
| 07/01/1997 | US5643727 BCL-2 gene inhibitory element binding factor |
| 07/01/1997 | US5643726 Integral membrane glycoproteins, genes and promoters |
| 07/01/1997 | US5643722 Marking proteins and detection, incubation |
| 07/01/1997 | US5643720 Method of inhibiting transcription utilizing nuclear receptors |
| 07/01/1997 | US5643714 Method and assay for HTLV |
| 07/01/1997 | US5643607 Prolonged release microcapsules |
| 07/01/1997 | US5643578 Subunit vaccines |
| 07/01/1997 | US5643575 Non-antigenic branched polymer conjugates |
| 07/01/1997 | US5643574 Protein- or peptide-cochleate vaccines and methods of immunizing using the same |
| 07/01/1997 | US5643572 Monoclonal antibody to urushiol |
| 07/01/1997 | US5643571 Adding immunized fish which release antibodies against pathogenic organisms such as protozoa and parasites |
| 07/01/1997 | US5643570 BPI-immunoglobulin fusion proteins |
| 07/01/1997 | US5643569 Preparation of agarose coated, solid agarose-collagen beads containing secretory cells |
| 07/01/1997 | US5643567 Antigrowth agents for tumors |
| 07/01/1997 | US5643566 Formulation processes for lipophilic proteins |
| 07/01/1997 | US5643565 Human IL-2 as a vaccine adjuvant |
| 07/01/1997 | US5643564 Glycosylated cytokines |
| 07/01/1997 | US5643563 N-∇3 deletion mutants of the short form of CSF-1 |
| 07/01/1997 | US5643464 Process for preparing a sterile, dry crosslinking agent |
| 07/01/1997 | US5643192 Fibrin glue including fibrinogen component and thrombin component both obtained solely from same single donor |
| 07/01/1997 | CA2128248C Amino acids useful as inhibitors of the advanced glycosylation of proteins |
| 06/26/1997 | WO1997022704A1 Mitogen-activated protein kinase kinase mek6 and methods of use therefor |
| 06/26/1997 | WO1997022702A1 Diagnosis and treatment of aur-1 and/or aur-2 related disorders |
| 06/26/1997 | WO1997022701A1 Equine rhinovirus 1 proteins |
| 06/26/1997 | WO1997022699A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
| 06/26/1997 | WO1997022698A2 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 06/26/1997 | WO1997022696A1 Utrophin gene expression |
| 06/26/1997 | WO1997022695A2 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | WO1997022690A2 SIGNALING INOSITOL POLYPHOSPHATE 5-PHOSPHATASES (SIPs) |
| 06/26/1997 | WO1997022625A1 Ghrh-rp compositions and methods |
| 06/26/1997 | WO1997022624A2 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
| 06/26/1997 | WO1997022623A1 Osteo antiviral protein |
| 06/26/1997 | WO1997022622A1 Betide-substituted gnrh antagonists |
| 06/26/1997 | WO1997022621A2 Antineoplastic peptides |
| 06/26/1997 | WO1997022620A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 06/26/1997 | WO1997022619A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022372A1 Use of injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
| 06/26/1997 | WO1997022364A1 FCε-PE CHIMERIC PROTEIN FOR TARGETED TREATMENT OF ALLERGY RESPONSES, A METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 06/26/1997 | WO1997022361A1 Sugar chain-recognizing antibody and remedy for infection with hiv |
| 06/26/1997 | WO1997022360A2 Control of protein synthesis, and screening method for agents |
| 06/26/1997 | WO1997022359A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation |
| 06/26/1997 | WO1997022358A1 Microemulsion preconcentrates comprising cyclosporins |
| 06/26/1997 | WO1997022357A1 Methods for treating prostate cancer with lhrh antagonists |
| 06/26/1997 | WO1997022356A1 Protected biopolymers for oral administration and methods of using same |
| 06/26/1997 | WO1997022347A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor. |
| 06/26/1997 | WO1997022255A1 p62 POLYPEPTIDES, RELATED POLYPEPTIDES, AND USES THEREFOR |
| 06/26/1997 | WO1997022250A1 Therapeutic molecules generated by trans-splicing |
| 06/26/1997 | WO1997020045A3 P2u2 purinergic receptor |
| 06/26/1997 | WO1997013845A3 Phosphopantetheinyl transferases and uses thereof |
| 06/26/1997 | DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector |
| 06/26/1997 | DE19549232A1 Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum zur Herstellung eines pharmazeutischen Präparates zur verstärkten Mobilisierung hämatopoetischer Stammzellen Use of G-CSF in combination with a chemotherapeutic agent for the preparation of a pharmaceutical composition for enhanced mobilization of hematopoietic stem cells |
| 06/26/1997 | DE19548476A1 Zielgerichtete Verbindungen mit knorpel- und/oder knocheninduzierender Aktivität Targeted compounds with cartilage and / or osteoinductive activity |
| 06/26/1997 | DE19548122A1 Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 06/26/1997 | DE19547991A1 Use of combinations of uricase and uric acid |
| 06/26/1997 | CA2241080A1 Control of protein synthesis, and screening method for agents |
| 06/26/1997 | CA2240938A1 Utrophin gene expression |
| 06/26/1997 | CA2240640A1 Microemulsion preconcentrates comprising cyclosporins |
| 06/26/1997 | CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/26/1997 | CA2240449A1 Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer |
| 06/26/1997 | CA2239787A1 Potentiation of complement and coagulation inhibitory properties of c1-inhibitor |
| 06/25/1997 | EP0780472A2 Stress proteins |
| 06/25/1997 | EP0780398A2 Process for purifying tammhorsfall glycoprotein or uromodulin, their purified products and method for making the discrimination between both of them |
| 06/25/1997 | EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions |
| 06/25/1997 | EP0780055A2 Nutritional coffee composition |
| 06/25/1997 | EP0779933A1 Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
| 06/25/1997 | EP0779923A2 Interleukin-1 type 3 receptors |
| 06/25/1997 | EP0779922A2 Modified human c3 proteins |
| 06/25/1997 | EP0779897A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
| 06/25/1997 | EP0779895A1 An improved process for preparing side chain derivatives of cyclohexapeptidyl lipopeptides |
| 06/25/1997 | EP0779819A1 Therapeutic treatment of clostridium difficile associated diseases |
| 06/25/1997 | EP0779816A1 Use of insulin-like growth factors (i) and (ii) for inhibition of inflammatory response |
| 06/25/1997 | EP0779813A1 Phosphonates and parathyroid hormone for osteoporosis |
| 06/25/1997 | EP0779812A1 Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 06/25/1997 | EP0779806A1 Sustained release preparation containing metal salt of a peptide |
| 06/25/1997 | EP0779805A2 Sustained release of peptides from pharmaceutical compositions |
| 06/25/1997 | EP0755261A4 Bandage for continuous application of biologicals |
| 06/25/1997 | EP0706376B1 Anti-angiogenic compositions and methods of use |
| 06/25/1997 | EP0696199A4 Amidino and guanidino substituted boronic acid inhibitors of trypsin-like enzymes |
| 06/25/1997 | EP0693874A4 Broad spectrum tumor suppressor genes, gene products and methods for tumor suppression gene therapy |
| 06/25/1997 | EP0641358A4 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR. |
| 06/25/1997 | EP0636141B1 Pyrimidinyl acetamides as elastase inhibitors |
| 06/25/1997 | CN1152940A Non-splicing variants of gp 350/220 |
| 06/25/1997 | CN1152939A Monoclonal antibodies which promote central nervous system remyelination |
| 06/25/1997 | CN1152937A Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 06/25/1997 | CN1152935A Papillomavirus vaccines |
| 06/25/1997 | CN1152925A Monoclonal antibody active against CD44V6 |